The VICC.ORG Directory of Cancers: Treatments, Services & Resources
Hematologic Cancers
The Hematology Clinic is located on the second floor of The Vanderbilt Clinic and is open from Monday through Friday from 8:00 a.m. to 5:00 p.m. Our physicians see patients with hematologic malignancies, benign hematologic disorders and specialty clinics for sickle cell anemia and hemostasis and thrombosis.
Types of Hematologic Cancers
Clinical Trials for Hematologic Cancers
31 Open Trials
| Trial Type & Disease | Protocol No. & Open Date | Summary |
|---|---|---|
| Therapeutic Hematologic | VICCBMT1148 05/11/2012 | A Randomized Phase II Study of Imatinib and Rituximab for Cutaneous Sclerosis after Allogeneic Hematopoietic Cell Transplantation (Consortium) |
| Therapeutic Leukemia; Pediatric Leukemia | COGAALL1131 04/05/2012 | A Phase III Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine (IND #73789, NSC# 606869) in the Very High Risk Stratum |
| Therapeutic Leukemia | ECOGHEME2906 01/20/2012 | Phase III Randomized Trial of Clofarabine as Induction and Post-Remission Therapy vs. Standard Daunorubicin & Cytarabine Induction and Intermediate Dose Cytarabine Post-Remission Therapy, Followed by Decitabine Maintenance vs. Observation in Newly-Diagnosed Acute Myeloid Leukemia in Older Adults (Age greater than or equal to 60 Years) |
| Therapeutic Lymphoma | VICCBMT1129 11/17/2011 | A Randomized Controlled Study of Extracorporeal Photopheresis (ECP) Therapy with UVADEX for the Treatment of Patients with Moderate to Severe Chronic Graft vs Host Disease |
| Therapeutic Multiple Myeloma | VICCBMT1049 11/17/2011 | A Trial of Single Autologous Transplant with or without Consolidation Therapy versus Tandem Autologous Transplant with Lenalidomide Maintenance for Patients with Multiple Myeloma |
| Therapeutic Leukemia; Lymphoma; Pediatric Leukemia | COGADVL1114 11/02/2011 | ADVL1114 - A Phase 1 Study of Temsirolimus (CCI-779, IND# 61010) in Combination with Intensive Re-induction Therapy for Children with Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkin Lymphoma |
| Therapeutic Leukemia | VICCHEM1096 10/24/2011 | A Phase III Randomized Study of Oral Sapacitabine in Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia |
| Therapeutic Hematologic | VICCBMT1158 10/20/2011 | A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients with Hematologic Malignancies and other Indications |
| Therapeutic Leukemia | ECOGBMTS0805 09/14/2011 | Phase II Study of Combination of Hyper-CVAD and Dasatinib (NSC-732517) With or Without Allogeneic Stem Cell Transplant in Patients with Philadelphia (Ph) Chromosome Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia |
| Therapeutic Lymphoma | VICCHEM1105 08/03/2011 | A Phase 2/3 Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Lenalidomide (Revlimid) versus Investigator's Choice in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma |
| Therapeutic Leukemia | VICCHEM1095 08/03/2011 | A Phase 3, Randomized, Controlled, Double-Blind, Multinational Clinical Study of the Efficacy and Safety of Vosaroxin and Cytarabine Versus Placebo and Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (VALOR) |
| Therapeutic Hematologic | VICCBMT1071 08/01/2011 | Targeted Therapy for Bronchiolitis Obliterans Syndrome (BOS) |
| Therapeutic Lymphoma | VICCDERM1059 06/01/2011 | Phase IV Randomized Study of Two Dose Levels of Targretin Capsules in Patients with Refractory Cutaneous T-Cell Lymphoma |
| Therapeutic Hematologic; Leukemia | ECOGHEMC10404 05/17/2011 | A Genetic Risk Stratified, Randomized Phase II Study of Four Fludarabine/Antibody Combinations for Patients with Symptomatic, Previously Untreated Chronic Lymphocytic Leukemia |
| Therapeutic Lymphoma | ECOGHEME2408 05/10/2011 | A 3-Arm Randomized Phase II Trial of Bendamustine-Rituximab (BR) Followed by Rituximab vs Bortezomib-BR (BVR) Followed by Rituximab vs BR Follwed by Lenalidomide/Rituximab in High Risk Follicular Lymphoma |
| Therapeutic Hematologic; Lymphoma | ECOGHEMC50604 05/09/2011 | Phase II Trial of Response-Adapted Chemotherapy Based on Positron Emission Tomography for Non-Bulky Stage I and II Hodgkin Lymphoma |
| Therapeutic Leukemia; Lymphoma; Pediatric Leukemia; Pediatric Lymphoma | COGAALL07P1 01/26/2011 | A Phase II Pilot Trial of Bortezomib (PS-341, Velcade, IND# 58,443) in Combination with Intensive Re-Induction Therapy for Children with Relapsed Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma (LL) |
| Therapeutic Leukemia | VICCPHI1050 01/17/2011 | A Phase Ib, Dose-Finding Study of Oral Panobinostat (LBH589) in Combination with Idarubicin and Cytarabine Induction and High-Dose Cytarabine-Based Consolidation Therapy in Adult Patients Less and or Equal to 65 Years Old with Acute Myeloid Leukemia (AML) |
| Therapeutic Lymphoma | ECOGHEMC50303 03/04/2010 | Phase III Study of R-CHOP v. Dose-Adjusted EPOCH-R with Molecular Profiling in Untreated De Novo Diffuse Large B-Cell Lymphomas |
| Therapeutic Lymphoma | VICCBMT0989 11/24/2009 | Phase II Trial of Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation for Patients with Relapsed Follicular Non-Hodgkin's Lymphoma Beyond First Complete Response |
| Therapeutic Lymphoma | VICCHEM0835 10/03/2008 | A Phase II Randomized Study of Lenalidomide or Lenalidomide and Rituximab as Maintenance Therapy Following Standard Chemotherapy for Patients with High/High-intermediate risk Diffuse Large B-Cell Lymphoma |
| Ancillary Leukemia | VICCHEM1073 08/19/2011 | The Role of the Native Immune System in Determining Outcome Following AML Induction Therapy |
| Ancillary Hematologic | ECOGHEME3903 06/07/2005 | Ancillary Laboratory Protocol for Collecting Diagnostic Material on Patients Considered for ECOG Treatment Trials for Leukemia or Related Hematologic Disorders |
| Correlative Lymphoma; Pediatric Lymphoma | COGAHOD04B1 10/05/2011 | AHOD04B1 - Hodgkin Disease (HD) Banking Study |
| Correlative Hematologic | VICCBMT1063 07/27/2011 | T-Regulatory Homing Subsets as a Predictor of Response in GVHD Treated with Extracorporeal Photopheresis |
| Correlative Leukemia | COGAALL08B1 10/18/2010 | Classification of Newly Diagnosed Acute Lymphoblastic Leukemia (ALL) |
| Correlative Leukemia | VICCPED0995 02/18/2010 | Detection of Donor-Derived DNA in Semen Samples Among Recipients of Allogeneic Hematopoietic Stem-Cell Transplants |
| Correlative Hematologic | NMDPBMT0346 07/09/2003 | Repository for National Donor Program (NMDP) Research Blood Samples. |
| Epidemiology, Observation, Outcomes Hematologic | VICCBMT1035 05/02/2011 | Longitudinal Study of Immune Mediated Disorders after Allogeneic Hematopoietic Cell Transplantation (HCT) |
| Epidemiology, Observation, Outcomes Lymphoma | VICCHEM1039 12/09/2010 | Prospective, Longitudinal, Multinational Registry of Patients with Newly Diagnosed Peripheral T-Cell Lymphoma |
| Screen, Detect, Diagnose Hematologic | VICCPED1159 10/21/2011 | A Screening Protocol to Identify Patients With AdV Viremia Post Allogeneic HSCT, a Companion Protocol to the Clinical Study "A Randomized, Placebo-Controlled, Multi-Site Phase 2 Study Evaluating the Safety and Efficacy of Preemptive Treatment with CMX001 for the Prevention of Adenovirus Disease Following Hematopoietic Stem Cell Transplantation (The ADV HALT Trial)" Protocol Number: CMX001-202SP |
You do not have JavaScript enabled. This site works better with JavaScript turned on.
